Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma

Background: The correlation between fibrinogen levels and adrenocortical carcinoma (ACC) remains unclear. This study aimed to explore the value of preoperative plasma fibrinogen as a biomarker for ACC. Methods: We identified 40 patients with ACC and 170 patients with adrenal adenoma (AA) who underwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengquan Ma, Bin Yang, Quanzong Mao
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/11795549241271657
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556217292390400
author Chengquan Ma
Bin Yang
Quanzong Mao
author_facet Chengquan Ma
Bin Yang
Quanzong Mao
author_sort Chengquan Ma
collection DOAJ
description Background: The correlation between fibrinogen levels and adrenocortical carcinoma (ACC) remains unclear. This study aimed to explore the value of preoperative plasma fibrinogen as a biomarker for ACC. Methods: We identified 40 patients with ACC and 170 patients with adrenal adenoma (AA) who underwent surgery at our institution between 2015 and 2022. Plasma fibrinogen levels and postoperative tumor recurrence information of the patients were also recorded. For intergroup comparisons, data obtained from the AA and ACC groups were evaluated using a t -test. The cutoff value of fibrinogen level was determined using a receiver operating characteristic (ROC) curve. Results: Mean fibrinogen levels in the AA and ACC groups were 2.81 ± 0.59 g/L and 3.88 ± 1.75 g/L, respectively ( P  < .001). Fibrinogen level, which can help distinguish between AA and ACC, was evaluated using the ROC curve. The cutoff fibrinogen level was estimated as 3.87 g/L according to the Youden index. With this value, the sensitivity was 62.5%, specificity was 95.7%, and the area under the ROC curve (AUC) was 0.74 ( P  < .001). Fibrinogen level, which can help distinguish between recurrence and non-recurrence, was evaluated using the ROC curve. The cutoff fibrinogen level was estimated as 3.96 g/L according to the Youden index. The sensitivity, specificity, and AUC were 90%, 71.4%, and 0.85, respectively ( P  < .001). Conclusion: According to the data in this study, plasma fibrinogen could be used to distinguish ACC from AA. Most importantly, plasma fibrinogen may be used to identify recurrence of postoperative ACC.
format Article
id doaj-art-309a3a55b158476b9d47b6da68705ab0
institution Kabale University
issn 1179-5549
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Clinical Medicine Insights: Oncology
spelling doaj-art-309a3a55b158476b9d47b6da68705ab02025-01-07T12:03:27ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492025-01-011910.1177/11795549241271657Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical CarcinomaChengquan Ma0Bin Yang1Quanzong Mao2Department of Urology, Tianjin Medical University General Hospital, Tianjin, ChinaDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaBackground: The correlation between fibrinogen levels and adrenocortical carcinoma (ACC) remains unclear. This study aimed to explore the value of preoperative plasma fibrinogen as a biomarker for ACC. Methods: We identified 40 patients with ACC and 170 patients with adrenal adenoma (AA) who underwent surgery at our institution between 2015 and 2022. Plasma fibrinogen levels and postoperative tumor recurrence information of the patients were also recorded. For intergroup comparisons, data obtained from the AA and ACC groups were evaluated using a t -test. The cutoff value of fibrinogen level was determined using a receiver operating characteristic (ROC) curve. Results: Mean fibrinogen levels in the AA and ACC groups were 2.81 ± 0.59 g/L and 3.88 ± 1.75 g/L, respectively ( P  < .001). Fibrinogen level, which can help distinguish between AA and ACC, was evaluated using the ROC curve. The cutoff fibrinogen level was estimated as 3.87 g/L according to the Youden index. With this value, the sensitivity was 62.5%, specificity was 95.7%, and the area under the ROC curve (AUC) was 0.74 ( P  < .001). Fibrinogen level, which can help distinguish between recurrence and non-recurrence, was evaluated using the ROC curve. The cutoff fibrinogen level was estimated as 3.96 g/L according to the Youden index. The sensitivity, specificity, and AUC were 90%, 71.4%, and 0.85, respectively ( P  < .001). Conclusion: According to the data in this study, plasma fibrinogen could be used to distinguish ACC from AA. Most importantly, plasma fibrinogen may be used to identify recurrence of postoperative ACC.https://doi.org/10.1177/11795549241271657
spellingShingle Chengquan Ma
Bin Yang
Quanzong Mao
Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
Clinical Medicine Insights: Oncology
title Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
title_full Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
title_fullStr Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
title_full_unstemmed Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
title_short Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma
title_sort diagnostic and predictive recurrence value of plasma fibrinogen in patients with adrenocortical carcinoma
url https://doi.org/10.1177/11795549241271657
work_keys_str_mv AT chengquanma diagnosticandpredictiverecurrencevalueofplasmafibrinogeninpatientswithadrenocorticalcarcinoma
AT binyang diagnosticandpredictiverecurrencevalueofplasmafibrinogeninpatientswithadrenocorticalcarcinoma
AT quanzongmao diagnosticandpredictiverecurrencevalueofplasmafibrinogeninpatientswithadrenocorticalcarcinoma